We hypothesized that the inhibition of LAG-3 expression, by inhibiting its regulation by YY1, offers an alternative to CPIs that could lead to the restoration of the anti-tumor CD8 T cell function and be effective in cases of resistance to CPIs. The gene discussed is CD8A; the disease is neoplasm.